However, gastrointestinal side effects related to GLP-1 RA need appropriate clinical management to mitigate risks and maximize the benefits of therapy in people with IBD
Research Use Only This product is intended for laboratory and research purposes only
However, with this surge in usage comes an increased risk of injuries and health complications
We're moving away from viewing obesity as a number on the scale and toward treating it as a complex chronic metabolic disease that influences diabetes, fatty liver disease, cardiovascular health, sleep apnea, kidney disease, and quality of life
There may still be an adjustment period because the medicine is absorbed differently, but this is not starting treatment from scratch
We also identified several further observational investigations